Featured Product In Books
Accelerating Generic Drug Development: The FDA’s New Plan for Increasing Generic Competition
$397.00
Accelerating Generic Drug Development explains the FDA’s new policy and shows how to navigate the new pathway to approval. Read More
Books
Company Core Data Sheets and Benefit-Risk Evaluations: A Drugmaker’s Guide to Postmarket Safety Reporting
$397.00
Data Integrity in the COVID-19 Era and Beyond — Part II: Key Issues in Data Integrity – Virtual Conference Recording/Transcript
$287.00
